Histone Deacetylase Inhibitor [EPC]

3874 reported adverse events

Drugs of this class: BELINOSTAT GIVINOSTAT ROMIDEPSIN VORINOSTAT

These side effects are most commonly reported by patients taking drugs of the Histone Deacetylase Inhibitor [EPC] class:

# Side effect Count
0 FEBRILE NEUTROPENIA 292
1 NAUSEA 285
2 PLATELET COUNT DECREASED 282
3 DIARRHOEA 271
4 THROMBOCYTOPENIA 257
5 VOMITING 235
6 ANAEMIA 222
7 FATIGUE 217
8 DISEASE PROGRESSION 197
9 OFF LABEL USE 193
See all common reactions for Histone Deacetylase Inhibitor [EPC]

Drugs of the Histone Deacetylase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYCOSIS FUNGOIDES REFRACTORY 2 0.3333
1 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT 19 0.2836
2 RADIATION HEPATITIS 6 0.2222
3 CD34 CELL COUNT DECREASED 2 0.2000
4 DUCHENNE MUSCULAR DYSTROPHY 12 0.1290
5 OVARIAN EPITHELIAL CANCER STAGE III 2 0.1250
6 HUMAN ANTI-MOUSE ANTIBODY POSITIVE 2 0.1176
7 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT 2 0.0769
8 MYCOSIS FUNGOIDES RECURRENT 2 0.0690
9 ANORECTAL INFECTION BACTERIAL 1 0.0667
See all enriched reactions for Histone Deacetylase Inhibitor [EPC]